COVADIS Summit IV, August 31st – September 1st2016, Rome

Schedule: Wednesday August 31, 2016 13:30 – 20:30
1. Introduction to Coronary Vasomotion Disorders International Study Group (COVADIS) Third Summit
TIMETOPICSPEAKER
1330 – 1335Welcome & IntroductionsNoel Bairey Merz, US
1335 – 1340Summit ObjectivesJohn Beltrame, AU
2. Japanese Coronary Spasm Association Registry
1340 – 1410Overview, JCS Abstract, and Planned Analyses/PublicationsHiroaki Shimokawa, JP
1410 – 1430DiscussionJuan Carlos Kaski, UK
3. Coronary Microvascular Dysfunction Registry
1430 – 1445Overview and Demonstration of the CMD Registry.
Registry Data Quality Review (initial 150-300 subjects)
Peter Ong, DE and Hiroaki Shimokawa, JP
1445 – 1545(each Steering Committee member submits 50)
Hiroaki Shimokawa, JP and Steering Committee
1545 – 1615BREAK
1615 – 1700CMD Registry FundingHiroaki Shimokawa, JP and Ornella Rimoldi, IT
1700 – 1730CMD Registry Policy and ProceduresNoel Bairey Merz, US
1730 – 1800Panel Discussion: CMD Policy & ProceduresUdo Sechtem, DE
4. Coronary Microvascular Dysfunction in Heart Failure
1800 – 1830Tako-tsubo Cardiomyopathy and CMDAbhiram Prasad, UK
1830 – 1900HFpEF and CMDNoel Bairey Merz, US
1900 – 2030Dinner
Schedule: Thursday Sep 1, 2016 8:00 – 12:00
5. Coronary Microvascular Dysfunction Therapies (includes 5 min discussion)
TIMETOPICSPEAKER
0800 – 0815Aerobic ExerciseEileen Handberg, US
0815 – 0830Endothelial Modulating Agents – Statins, L-Arg, ACE-IJuan Carlos Kaski, UK
0830 – 0845Nitrates, Calcium Channel Blockers, IvabradineGaetano Lanza, IT
0900 – 0930BREAKFAST BREAK and check-out
0930 – 0945Nicorandil & Rho Kinase InhibitorsHiroaki Shimokawa, JP
0945 – 1000Ranolazine and Xanthine DerivativesFilippo Crea, Rome, IT
1000 – 1015Enhanced External Counter Pulsation (EECP)K Kronhaus, US
1015 – 1030Cardiac Nociception Targets: Tricyclics, Stellate Ganglion Block, Spinal Stimulators, Cognitive BehavioralPuja Mehta, US
1030 – 1045Meta-analysis of Trials in Angina with Normal Coronary ArteriesRaffaele De Caterina, IT
6. Future Directions of COVADIS
1045 – 1100Is a COVADIS Clinical Trial Possible?John Beltrame, AU
1100 – 1115COVADIS Summit-2017 (Barcelona) Publication ReviewUdo Sechtem, DE
Steering Committee Writing Group (Thursday Sep 1, 2016 12:00-17:00)
C. Noel Bairey Merz, US, John Beltrame, AU, Paolo Camici, IT, Filippo Crea, IT, Juan Carlos Kaski, UK, Peter Ong, DE, Udo Sechtem, DE, Hiro Shimokawa, JP.